Advances in hospital medicine: A review of key articles from the literature

Medical Clinics of North America

Volumn 86, Issue 4, 2002, Pages 797-823

  Williams, Mark V ^a   Huddleston, Jeanne ^b   Whitford, Kevin ^b   DiFrancesco, Lorenzo ^a   Wilson, Mitchell ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CALCIUM ANTAGONIST; CEPHALOSPORIN DERIVATIVE; D DIMER; DIGOXIN; DILTIAZEM; DOBUTAMINE; DROTRECOGIN; ECHINACEA EXTRACT; EPHEDRA EXTRACT; ESMOLOL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; MACROLIDE; METOPROLOL; PLANT EXTRACT; PROPRANOLOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALRIAN EXTRACT; VANCOMYCIN; VERAPAMIL;

AGING; ANTIBIOTIC THERAPY; BIOASSAY; BLEEDING; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HERBAL MEDICINE; HOSPITAL CARE; HUMAN; INTERPERSONAL COMMUNICATION; KNEE ARTHROPLASTY; LENGTH OF STAY; LOBAR PNEUMONIA; LUNG EMBOLISM; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; SLEEP APNEA SYNDROME; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; THORAX DRAINAGE; TUBE FEEDING; VASCULAR SURGERY;

EID: 0036656617     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00023-8     Document Type: Note

References (41)

1. Dudas V, Hopefl A, Jacobs R, et al. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharm 2000;34:446-52.
2. Gleason PP, Meehan T, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159:2562-72.
3. Wells P, Anderson D, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-20.
4. Mullins M, Becker D, Hagspiel K, et al. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000;160: 293-8.
5. Rathbun S, Raskob G, Whitsett T. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000;132:227-32.
6. Perrier A, Desmarais S, Miron M, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999;353:190-5.
7. Perrier A, Miron M, Desmarais S, et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: is it a valid option in patients with normal results of lower-limb venous compression ultrasonography. Arch Intern Med 2000;160:512-6.
8. Breen CM, Abernethy AP, Abbott KH, et al. Conflict associated with decisions to limit life-sustaining treatment in intensive care units. Journal of General Internal Medicine 2001;16:283-9.
9. Schneiderman LJ, Gilmer T, Teetzel HD. Impact of ethics consultations in the intensive care setting: a randomized, controlled trial. Crit Care Med 2000;28:3920-4.
10. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995;274:1591-8.
11. Lilly CM, De Meo DL, Sonna LA, et al. An intensive communication intervention for the critically ill. American Journal of Medicine 2000;109:469-75.
12. Gessert CE, Mosier MC, Brown EF, et al. Tube feeding in nursing home residents with severe and irreversible cognitive impairment. Journal of the American Geriatrics Society 2000;48:1593-600.
13. Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999;282:1365-70.
14. Gillick MR. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med 2000;342:206-10.
15. Sheiman SL. Tube feeding the demented nursing home resident. J Am Geriatr Soc 1996;44:1268-70.
16. Mitchell SL, Berkowitz RE, Lawson FM, et al. A cross-national survey of tube-feeding decisions in cognitively impaired older persons. Journal of the American Geriatrics Society 2000;48:391-7.
17. Mitchell SL, Kiely DK, Lipsitz LA. The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Archives of Internal Medicine 1997;157:327-32.
18. Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respiratory Medicine 1998;92:593-6.
19. Marom EM, Patz Jr EF, Erasmus JJ, et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999;210:277-81.
20. Patz Jr EF, McAdams HP, Erasmus JJ, et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998;113:1305-11.
21. Seaton KG, Patz Jr EF, Goodman PC. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR. Am J Roentgenol 1995;164:589-91.
22. Patz Jr EF, McAdams HP, Goodman PC, et al. Ambulatory sclerotherapy for malignant pleural effusions. Radiology 1996;199:133-5.
23. Petty T, Weinman G. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995. JAMA 1997; 277:246-53.
24. Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001;134:595-9.
25. Bach PB, Brown C, Gelfand S, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence. Ann Intern Med 2001;134:600-20.
26. Valentin F, Lars ER, Asinger RW, et al. Guidelines for the management of patients with atrial fibrillation. Journal of the American College of Cardiology 2001;38:1231-66.
27. Baily D, Lehmann MH, Schumacher DN, et al. Hospitalization for Arrhythmias in the United States: Importance of atrial fibrillation. Journal of the American College of Cardiology 1992;19:41A.
28. Feinberg WM, Cornell ES, Nightingale SD. Relationship between prothrombin activation fragment F1.2 and international nomalized ratio in patients with atrial fibrillation. Stroke 1997;28:1101-6.
29. Ostranderld JR, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community, Tecumshe, Michigan. Circulation 1965; 31:888-98.
30. Krahn AD, Manfreda J, Tate RB, et al. The natural history of artrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-up study. American Journal Medicine 1995;98:476-84.
31. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-61.
32. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987;147:1561-4.
33. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994;271:840-4.
34. Hart RG, Halperin JL. Artrial fibrillation and thromboembolism: a decade of progress in stroke prevenetion. Ann Intern Med 1999;131:688-95.
35. Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology 1978;28:973-7.
36. Wolf PA, Abbott RD, Kannel WB. Arrial fibrillation as an independent ristk factor for stroke: the Farmingham Study. Stroke 1991;22:983-8.
37. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in artrial fibrillation: pharmacological intervention in artrial fibrillation (PIAF). A randomized trial. Lancet 2000;356:1789-94.
38. Lemery R, Brugda P, Cheriex E, et al. Reverrsibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable artrial fibrillation. American J Cardiol 1987;60:1406-8.
39. Valentin F, Lars ER, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. Journal of the American College of Cardiology 2001; 38:1231-66.
40. Farshi R, Kistner D, Sarma JS, et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. Journal of the American College of Cardiology 1993;33:304-10.
41. Scardi S, Humar F, Pandullo C, et al. Oral clonidine for heart rate control in chronic atrial fibrillation. Lancet 1993;1341:1211-12 (letter).